Gliadin and Celiac Disease

Gliadin, a glycoprotein consisting of a carbohydrate and a protein, is a constituent of gluten found in wheat as well as other grains such as oats, rye, barley, and millet. It is an essential component of gluten, which is responsible for the proper rising of bread during baking. Individuals with celiac disease, Crohn's disease, and other related conditions may exhibit sensitivity to gliadin when consumed in their diet. In such conditions, the presence of antibodies specifically targeting gliadin can frequently be identified in the bloodstream.

Browse all Gliadin products

Types of Gliadin

Gliadins are categorized into three main types: α, γ, and ω gliadins. These types are distinguished based on their amino acid sequences in the N-terminal cysteine domain. α-/β-gliadins are soluble in low-percentage alcohols, while γ-gliadins are ancestral forms of cysteine-rich gliadins with only intrachain disulfide bridges. On the other hand, ω-gliadins are soluble in higher percentages, specifically 30-50% acidic acetonitrile.

The Role of Gliadin in Celiac Disease

Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. Celiac disease affects an estimated 60,000 individuals annually, making it a prevalent genetically linked disorder in the United States. Gliadin, a component of gluten, has been identified as the primary culprit in celiac disease.

Triggering the Inflammatory Cascade

When gliadin is ingested by individuals with a genetic predisposition, gliadin peptides set off a cascade of inflammatory reactions within the body. These peptides, with their unique amino acid composition, are recognized by the immune system as foreign invaders, prompting an aggressive response from helper T-cells. The activation of these T-cells unleashes a wave of inflammatory cytokines and chemokines, which in turn, trigger the characteristic intestinal damage seen in celiac disease. This damage manifests as the destruction of the delicate villi, the finger-like projections that line the small intestine and facilitate nutrient absorption.

The Genetic Connection

Celiac disease is not merely an environmental reaction to a dietary protein, it is deeply rooted in an individual's genetic makeup. The human leukocyte antigens (HLA) DQ2 and DQ8, which are part of the major histocompatibility complex (MHC), are strongly associated with an increased risk of developing the condition.

These genetic markers play a crucial role in the autoimmune response by enhancing the body's ability to bind and present the gluten-derived gliadin peptides to the immune system. This heightened recognition of the "foreign" gliadin triggers the aggressive response from helper T-cells, ultimately leading to the characteristic intestinal inflammation and damage.

The Enzymatic Transformation

Gliadin peptides, with their high proline and glutamine content, are ideal substrates for the enzyme tissue transglutaminase (tTG). This enzyme, which is abundant in the small intestine, serves to convert the glutamine residues within gliadin into negatively charged glutamic acid residues.

This modification creates active T-cell epitopes that are then recognized by the immune system, further amplifying the autoimmune reaction. The interplay between genetic predisposition, the environmental trigger of gliadin exposure, and the enzymatic transformation of gliadin peptides is the linchpin of celiac disease pathogenesis.

Zonulin Release

In celiac disease, exposure to the gluten-derived peptide gliadin triggers the release of the protein zonulin from the small intestine's endothelial cells. Importantly, this zonulin elevation occurs regardless of whether an individual has the genetic predisposition for celiac disease. Zonulin is associated with the breakdown of the tight junctions between intestinal epithelial cells, compromising the intestinal barrier. This allows the indiscriminate passage of various substances, including toxins, microbes, undigested food particles, and antibodies produced to target the gliadin peptide.

The presence of these antibodies in the circulation leads to an augmented autoimmune response, causing further damage to the epithelial cells. This cascade of events results in increased intestinal inflammation and permeability. As intestinal damage progresses, the absorptive capacity of the intestinal microvilli becomes impaired, potentially resulting in nutrient deficiencies.

Nutrient Malabsorption and Associated Complications

The intestinal damage caused by the gliadin-driven autoimmune response in celiac disease has far-reaching consequences. The destruction of the villi compromises the body's ability to properly absorb essential nutrients, leading to a multitude of deficiencies. One of the most common nutrient deficiencies associated with celiac disease is vitamin B12. Similarly, folate and iron deficiencies are prevalent in untreated celiac disease.

Gliadin-Antibodies

Gliadin-Antigens

Gliadin-ELISA Kits